Antonio López–Pousa

9.0k total citations
161 papers, 3.4k citations indexed

About

Antonio López–Pousa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Antonio López–Pousa has authored 161 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Pulmonary and Respiratory Medicine, 80 papers in Oncology and 34 papers in Surgery. Recurrent topics in Antonio López–Pousa's work include Sarcoma Diagnosis and Treatment (96 papers), Vascular Tumors and Angiosarcomas (37 papers) and Head and Neck Cancer Studies (23 papers). Antonio López–Pousa is often cited by papers focused on Sarcoma Diagnosis and Treatment (96 papers), Vascular Tumors and Angiosarcomas (37 papers) and Head and Neck Cancer Studies (23 papers). Antonio López–Pousa collaborates with scholars based in Spain, Italy and United States. Antonio López–Pousa's co-authors include Javier Martín‐Broto, Miquel Quer, Javier Martínez‐Trufero, Andrés Poveda, Santiágo Díez, Xavier García del Muro, Antonio Casado, Joan Maurel, Ricardo Hitt and J. Buesa and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer.

In The Last Decade

Antonio López–Pousa

148 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio López–Pousa Spain	32	1.9k	1.7k	804	771	541	161	3.4k
Mark Agulnik United States	36	2.1k 1.1×	2.6k 1.5×	782 1.0×	615 0.8×	847 1.6×	165	4.2k
Javier Martínez‐Trufero Spain	20	1.1k 0.6×	976 0.6×	533 0.7×	519 0.7×	199 0.4×	124	2.0k
Anne Kirkpatrick Belgium	14	2.5k 1.3×	1.9k 1.2×	1.6k 2.0×	1.9k 2.5×	468 0.9×	16	4.4k
Emmanuelle Bompas France	38	4.1k 2.2×	2.6k 1.6×	912 1.1×	141 0.2×	784 1.4×	197	5.8k
Annette Ramaswamy Germany	35	652 0.4×	1.8k 1.1×	999 1.2×	226 0.3×	1.2k 2.3×	110	3.7k
Flavio Crippa Italy	30	1.1k 0.6×	1.1k 0.7×	729 0.9×	101 0.1×	340 0.6×	124	3.2k
A.M. Cassoni United Kingdom	20	967 0.5×	751 0.4×	680 0.8×	109 0.1×	379 0.7×	37	2.2k
Masao Hosokawa Japan	36	1.7k 0.9×	852 0.5×	1.9k 2.4×	397 0.5×	1.2k 2.2×	112	3.8k
Kenneth S. Hu United States	25	904 0.5×	987 0.6×	1.0k 1.3×	1.0k 1.3×	241 0.4×	133	2.6k
S. Jelić Serbia	20	838 0.5×	1.4k 0.8×	987 1.2×	968 1.3×	310 0.6×	70	2.7k

Countries citing papers authored by Antonio López–Pousa

Since Specialization

Citations

This map shows the geographic impact of Antonio López–Pousa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio López–Pousa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio López–Pousa more than expected).

Fields of papers citing papers by Antonio López–Pousa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio López–Pousa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio López–Pousa. The network helps show where Antonio López–Pousa may publish in the future.

Co-authorship network of co-authors of Antonio López–Pousa

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio López–Pousa. A scholar is included among the top collaborators of Antonio López–Pousa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio López–Pousa. Antonio López–Pousa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Palmerini, Emanuela, Vittorio Quagliuolo, Javier Martín‐Broto, et al.. (2024). Redefining radiologic responses (RR) in solid tumors: Shall we brace ourselves for a post-RECIST era? Results from a randomized clinical trial (RCT) on neoadjuvant chemotherapy in high-risk soft-tissue sarcomas (HR-STS) of the trunk or extremities.. Journal of Clinical Oncology. 42(16_suppl). 11553–11553.

Tap, William D., Vivek A. Bhadri, Silvia Stacchiotti, et al.. (2024). Efficacy, safety, and patient-reported outcomes of vimseltinib in patients with tenosynovial giant cell tumor: Results from the phase 3 MOTION trial.. Journal of Clinical Oncology. 42(16_suppl). 11500–11500. 2 indexed citations

Förster, Martin, Irene Braña, Antonio López–Pousa, et al.. (2024). Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 30(17). 3726–3734. 8 indexed citations

Palmerini, Emanuela, Antonio López–Pousa, Giovanni Grignani, et al.. (2024). Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single‐arm, phase 2 trial. Cancer. 131(1). e35628–e35628. 6 indexed citations

D’Angelo, Sandra P., Andrew Furness, Fiona Thistlethwaite, et al.. (2024). Lete-cel in patients with synovial sarcoma or myxoid/round cell liposarcoma: Planned interim analysis of the pivotal IGNYTE-ESO trial.. Journal of Clinical Oncology. 42(16_suppl). 2500–2500. 9 indexed citations

Serrano, César, Javier Martín‐Broto, José Manuel Asencio, et al.. (2023). 2023 GEIS Guidelines for gastrointestinal stromal tumors. Therapeutic Advances in Medical Oncology. 15. 2637124–2637124. 38 indexed citations

Martín‐Broto, Javier, Jerónimo Martínez-García, David S. Moura, et al.. (2023). Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A. Signal Transduction and Targeted Therapy. 8(1). 405–405. 15 indexed citations

Martín‐Broto, Javier, Andrés Redondo, David S. Moura, et al.. (2022). A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors. Nature Communications. 13(1). 6278–6278. 2 indexed citations

Martín‐Broto, Javier, Antonio López–Pousa, Andrew S. Brohl, et al.. (2020). Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma. Molecular Cancer Therapeutics. 20(1). 132–141. 9 indexed citations

10.

Martín‐Broto, Javier, Nadia Hindi, Giovanni Grignani, et al.. (2020). Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial. Journal for ImmunoTherapy of Cancer. 8(2). e001561–e001561. 117 indexed citations

11.

Pavón, Miguel Ángel, Irene Arroyo‐Solera, Xavier León, et al.. (2019). The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial‐like head and neck carcinoma subtypes. Head & Neck. 41(6). 1830–1845. 9 indexed citations

12.

Arroyo‐Solera, Irene, Miguel Ángel Pavón, Xavier León, et al.. (2018). Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma. Head & Neck. 41(2). 429–439. 28 indexed citations

13.

Joensuu, Heikki, Jean‐Yves Blay, Alessandro Comandone, et al.. (2017). Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib. British Journal of Cancer. 117(9). 1278–1285. 33 indexed citations

14.

López–Pousa, Antonio, Miquel Quer, Mercedes Camacho, et al.. (2016). Risk of distant metastases in head and neck carcinoma patients and myeloperoxidase (MPO) expression.. Journal of Clinical Oncology. 34(15_suppl). 6067–6067. 1 indexed citations

15.

Gronchi, Alessandro, S. Frustaci, Mario Mercuri, et al.. (2012). Short, Full-Dose Adjuvant Chemotherapy in High-Risk Adult Soft Tissue Sarcomas: A Randomized Clinical Trial From the Italian Sarcoma Group and the Spanish Sarcoma Group. Journal of Clinical Oncology. 30(8). 850–856. 120 indexed citations

16.

Demetri, George D., Patrick Schöffski, Manisha H. Shah, et al.. (2012). Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure. Clinical Cancer Research. 18(11). 3170–3179. 102 indexed citations

17.

Muro, Xavier García del, Antonio López–Pousa, Joan Maurel, et al.. (2011). Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study. Journal of Clinical Oncology. 29(18). 2528–2533. 197 indexed citations

18.

León, Xavier, et al.. (2011). Sarcomas de cabeza y cuello. Nuestra experiencia. Acta Otorrinolaringológica Española. 62(6). 436–442. 2 indexed citations

19.

Muro, Xavier García del, Javier Martı́n, Joan Maurel, et al.. (2011). Guía de práctica clínica en los sarcomas de partes blandas. Medicina Clínica. 136(9). 408.e1–408.e18. 10 indexed citations

20.

López–Pousa, Antonio, Javier Martín‐Broto, Joaquín Montalar, et al.. (2006). Phase II Trial of Doxorubicin Plus Escalated High‐Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS). Sarcoma. 2006(1). 26986–26986. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact